查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1453918

到 2030 年空膠囊（藥物）市場預測：按類型、原產地、原料、功能、應用、最終用戶和地區進行的全球分析

Empty Capsules Market Forecasts to 2030 - Global Analysis By Type (Gelatin Capsules and Non-gelatin Capsules), Source (Porcine, Bovine and Natural), Raw Material, Functionality, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球空膠囊（藥物）市場規模為 33 億美元，預計預測期內年複合成長率為 8.6%，到 ​​2030 年將達到 58.8 億美元。

空膠囊（藥物）是一種通常由明膠或其他合適的聚合物製成的藥物外殼。用作口服各種藥物、補充品和草藥的容器。這些膠囊有不同的尺寸、顏色和形狀，以適應不同的配方和劑量要求。空膠囊（藥物）提供了一種方便且無味的藥物傳遞方法，特別是對於吞嚥錠劑有困難或不喜歡液體藥物味道的人來說。

根據世界衛生組織（WHO）預測，60歲及以上的人口將從2000年的6.05億增加到2050年的20億。據 DealsOnHealth 稱，到 2021 年，全球整體60 歲以上的女性中有 35% 每天都會使用美容產品。

製藥業的成長

隨著製藥公司擴大研發以創新新藥物和配方，對空膠囊（藥物）的需求不斷增加。這些膠囊由於其多功能性、易於吞嚥以及與各種製劑的相容性而成為各種藥品的首選劑型。個人化醫療的不斷成長趨勢和利基藥物的發展進一步推動了對空膠囊（藥物）的需求，因為它們提供精確的劑量和易於自訂。

品管與保證

空膠囊（藥物）的品管和保證包括嚴格的措施，以確保膠囊符合監管標準和客戶期望。這包括對原料、製造流程和成品進行嚴格測試，以確保均勻性、穩定性和安全性。品管的重點是檢測製造過程中的缺陷和偏差，而品質保證的重點是建立系統和通訊協定以防止問題發生。遵守良好生產規範 (GMP) 以及定期審核和檢查以保持一致性和可靠性至關重要。

素食/純素膠囊

素食膠囊通常由植物纖維素製成，適合因飲食、道德或宗教原因而避免使用動物源產品的人。同樣，不含所有動物性成分的純素膠囊吸引了越來越多的採用植物來源飲食的人。這一趨勢促使製造商創新地提供傳統明膠膠囊的植物來源替代品，開拓了一個利基市場，對道德和永續產品的需求不斷成長。隨著消費者對自己的選擇更加了解，對素食和純素膠囊的需求預計只會增加，這為我們提供的空膠囊（藥品）領域的公司創造了利潤豐厚的機會。

與替代輸送系統的競爭

隨著軟膠囊、錠劑和軟糖等各種替代給藥方法的出現，對傳統空膠囊（藥物）的需求可能會減少。這些替代系統通常具有改善口味、易於食用和提高生物利用度等優點，對消費者俱有吸引力。此外，技術的進步使得能夠滿足特定需求和偏好的創新輸送系統的開發成為可能。為了保持競爭力，空膠囊（藥品）市場的製造商必須注重創新、品質和市場競爭，以使其產品脫穎而出並應對不斷變化的消費者偏好。

COVID-19 的影響：

供應鏈和製造業的中斷導致製造空膠囊（藥物）所需的原料短缺，導致生產延誤和價格上漲。疫情食品對藥品和營養補充的需求增加，進一步收緊了空膠囊（藥物）的供應，而空膠囊（藥品）對於封裝藥品和補充品至關重要。空膠囊（藥品）市場的公司必須透過供應鏈多元化、探索替代採購選項以及投資提高產能來適應這些挑戰。

明膠膠囊細分市場預計將在預測期內成為最大的細分市場

明膠膠囊源自動物膠原蛋白，由於生物分解性、易於消化以及與多種配方的相容性而廣受歡迎。此外，它還為食品和營養補充提供出色的穩定性。對營養補充的需求不斷成長，加上全球製藥業的擴張，正在推動成長。

發炎藥物領域預計在預測期內年複合成長率最高

由於關節炎、發炎性腸道疾病和氣喘等發炎疾病的盛行率不斷上升，空膠囊（藥品）市場的發炎藥物領域正在顯著成長。隨著患者尋求方便的劑型，空膠囊為藥物封裝提供了多功能且可客製化的解決方案。藥物遞送技術的進步使得能夠開發出具有改善的生物有效性和標靶遞送的新型製劑。此外，人口老化加上久坐的生活方式正在增加發炎疾病的盛行率，推動市場擴張。

佔比最大的地區：

在北美，由於對藥品和營養補充的需求不斷增加，空膠囊（藥物）市場正在經歷顯著成長。健康意識的增強和人口老化正在促進營養補充食品的擴張，並推動對空膠囊（藥物）的需求。此外，FDA 等組織制定的監管核准和品質標準也增強了消費者的信心，進一步促進了市場成長。此外，該地區主要企業的存在和強大的分銷網路使製造商可以輕鬆獲得空膠囊（藥物），從而促進市場擴張。

年複合成長率最高的地區：

由於製藥和營養補充行業的成長、食品意識的增強以及可支配收入的增加，亞太地區的空膠囊（藥物）市場正在顯著成長。膠囊技術的進步和消費者對膠囊配方日益成長的偏好正在促進市場擴張。該地區人口基數大，老年人口不斷增加，為空膠囊（藥品）創造了巨大的市場，特別是在中國、印度和日本等國家。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球空膠囊（藥物）市場：依類型

  • 明膠膠囊
    • 硬明膠膠囊
    • 軟明膠膠囊
  • 非明膠膠囊

第6章全球空膠囊（藥品）市場：依產地分類

  • 豬
  • 牛
  • 海洋
  • 自然的

第7章全球空膠囊（藥品）市場：依原料分類

  • 羥丙基甲基纖維素（HPMC）
  • 澱粉原料
  • 普魯蘭膠

第8章全球空膠囊（藥品）市場：依功能分類

  • 即時釋放
  • 持續釋放
  • 延遲釋放

第9章全球空膠囊（藥品）市場：依應用分類

  • 制酸劑和腸道調節劑
  • 營養補充食品
  • 心血管藥物
  • 發炎藥
  • 抗生素和抗菌藥物
  • 咳嗽藥和感冒藥
  • 貧血預防藥
  • 其他用途

第10章全球空膠囊（藥品）市場：依最終用戶分類

  • 製藥和生物製藥公司
  • 營養保健品公司
  • 其他最終用戶

第11章全球空膠囊（藥品）市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司簡介

  • ACG Worldwide
  • Bright Pharma Caps Inc
  • CapsCanada Corporation
  • Healthcaps India Ltd
  • Lonza Group
  • Medi-Caps Ltd
  • Nectar Lifesciences Ltd
  • Qingdao Yiqing Medicinal Capsules Co. Ltd
  • Qualicaps Inc
  • Roxlor LLC
  • Shanxi JC Biological Technology Co. Ltd
  • Snail Pharma Industry Co. Ltd
  • Suheung Capsule Co. Ltd
  • Sunil Healthcare Ltd
Product Code: SMRC25470

According to Stratistics MRC, the Global Empty Capsules Market is accounted for $3.30 billion in 2023 and is expected to reach $5.88 billion by 2030 growing at a CAGR of 8.6% during the forecast period. Empty capsules are pharmaceutical shells typically made from gelatin or other suitable polymers. They serve as containers for administering various medications, supplements, or herbal remedies orally. These capsules come in different sizes, colors, and shapes to accommodate diverse formulations and dosage requirements. Empty capsules provide a convenient and tasteless way to deliver medications, especially for individuals who have difficulty swallowing tablets or dislike the taste of liquid medications.

According to the World Health Organization (WHO), the population aged 60 years and above will increase from 605 million in 2000 to 2 billion in 2050. According to DealsOnHealth, in 2021, globally, 35% of women above 60 or older use beauty products every day.

Market Dynamics:

Driver:

Pharmaceutical industry growth

As pharmaceutical companies expand their research and development efforts to innovate new drugs and formulations, the demand for empty capsules rises. These capsules serve as a preferred dosage form for various drugs due to their versatility, ease of swallowing, and compatibility with different formulations. The growing trend towards personalized medicine and the development of niche drugs further fuel the demand for empty capsules, as they offer precise dosing and easy customization.

Restraint:

Quality control and assurance

Quality control and assurance in the empty capsule market involves stringent measures to ensure that capsules meet regulatory standards and customer expectations. This encompasses rigorous testing of raw materials, manufacturing processes, and finished products to guarantee uniformity, stability, and safety. Quality control focuses on detecting defects and deviations during production, while quality assurance involves implementing systems and protocols to prevent issues before they occur. Adherence to Good Manufacturing Practices (GMP) is paramount, alongside regular audits and inspections to maintain consistency and reliability.

Opportunity:

Vegetarian and vegan capsules

Vegetarian capsules, typically made from plant cellulose, cater to individuals who avoid animal-derived products for dietary, ethical, or religious reasons. Similarly, vegan capsules, which exclude all animal-derived ingredients, appeal to a growing segment of the population embracing plant-based diets. This trend has prompted manufacturers to innovate and offer plant-based alternatives to traditional gelatin capsules, tapping into a niche market with increasing demand for ethical and sustainable products. As consumers become more conscious of their choices, the demand for vegetarian and vegan capsules is expected to continue its upward trajectory, presenting a lucrative opportunity for businesses operating in the empty capsules sector.

Threat:

Competition from alternative delivery systems

With the emergence of various alternative delivery methods such as softgels, tablets, and gummies, the demand for traditional empty capsules may decline. These alternative systems often offer advantages such as improved taste, ease of consumption, and enhanced bioavailability, making them appealing to consumers. Additionally, advancements in technology have enabled the development of innovative delivery systems that cater to specific needs and preferences. To remain competitive, manufacturers in the empty capsule market must focus on innovation, quality, and customization to differentiate their products and adapt to changing consumer preferences.

Covid-19 Impact:

With the global disruption in supply chains and manufacturing, there has been a shortage of raw materials required for producing empty capsules, leading to production delays and increased prices. The increased demand for pharmaceuticals and nutraceuticals during the pandemic has further strained the supply of empty capsules, as they are essential for encapsulating drugs and supplements. Companies in the empty capsule market have had to adapt to these challenges by diversifying their supply chains, exploring alternative sourcing options, and investing in increased production capacity.

The gelatin capsules segment is expected to be the largest during the forecast period

The gelatin capsules segment has experienced robust growth within the empty capsule market as Gelatin capsules are derived from animal collagen, which have gained popularity due to their biodegradability, ease of digestion, and compatibility with a wide range of formulations. Moreover, they offer excellent stability for both pharmaceutical and nutraceutical products. The rising demand for dietary supplements, coupled with the expanding pharmaceutical industry globally, has fueled the growth.

The anti-inflammatory drugs segment is expected to have the highest CAGR during the forecast period

The anti-inflammatory drug segment within the empty capsule market has witnessed notable growth due to the rising prevalence of inflammatory disorders such as arthritis, inflammatory bowel disease, and asthma. As patients seek convenient dosage forms, empty capsules offer a versatile and customizable solution for drug encapsulation. Advancements in drug delivery technologies have enabled the development of novel formulations with improved bioavailability and targeted delivery. Moreover, the aging population, coupled with sedentary lifestyles, has contributed to the growing incidence of inflammatory conditions, fostering market expansion.

Region with largest share:

The North American region has experienced significant growth in the empty capsule market because of increased demand for pharmaceuticals and dietary supplements. Rising health consciousness and a growing aging population have contributed to the expansion of the nutritional supplement industry, driving the demand for empty capsules. Regulatory approvals and quality standards set by organizations such as the FDA have also instilled confidence in consumers, further boosting market growth. Additionally, the presence of key players and robust distribution networks within the region has facilitated market expansion, ensuring easy availability of empty capsules to manufacturers.

Region with highest CAGR:

The Asia-Pacific region has witnessed substantial growth in the empty capsule market due to increasing pharmaceutical and nutraceutical industries, coupled with rising healthcare awareness and disposable incomes. Advancements in capsule technology and growing consumer preference for capsule-based formulations contribute to market expansion. The region's large population base and expanding geriatric demographic create a substantial market for empty capsules, particularly in countries like China, India, and Japan.

Key players in the market

Some of the key players in Empty Capsules market include ACG Worldwide, Bright Pharma Caps Inc, CapsCanada Corporation, Healthcaps India Ltd, Lonza Group, Medi-Caps Ltd, Nectar Lifesciences Ltd, Qingdao Yiqing Medicinal Capsules Co. Ltd, Qualicaps Inc, Roxlor LLC, Shanxi JC Biological Technology Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Capsule Co. Ltd and Sunil Healthcare Ltd.

Key Developments:

In February 2024, Lonza has announced the launch of its new performance nutrition brand, Oceanix(TM) in the U.S.A and Canada. The unique phytoplankton ingredient is sustainably sourced from the ocean and meets rising demand for natural, non-GMO and vegan supplement products. Oceanix(TM) ingredient offers potential benefits for physical performance and an increased physiological response against oxidative stress to aid recovery in a small, concentrated dose.

In December 2023, Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group. This strategic investment offers Roquette the ability to expand the global footprint of its pharmaceutical business, as well as enrich its offerings of oral dosage solutions. Roquette's deep knowledge and expertise in the development of pharmaceutical excipients will be further enhanced by Qualicaps' expertise in capsules, as well as by their assets and infrastructure.

Types Covered:

  • Gelatin Capsules
  • Non-gelatin Capsules

Sources Covered:

  • Porcine
  • Bovine
  • Marine
  • Natural

Raw Materials Covered:

  • Hydroxy Propyl Methyl Cellulose (HPMC)
  • Starch Materials
  • Pullulan

Functionalities Covered:

  • Immediate Release
  • Sustained Release
  • Delayed Release

Applications Covered:

  • Antacid & Antiflatulent Preparations
  • Dietary Supplements
  • Cardiovascular Therapy Drugs
  • Anti-inflammatory Drugs
  • Antibiotic & Antibacterial Drugs
  • Cough & Cold Drugs
  • Antianemic Preparations
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biopharmaceutical Companies
  • Nutraceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Empty Capsules Market, By Type

  • 5.1 Introduction
  • 5.2 Gelatin Capsules
    • 5.2.1 Hard Gelatin Capsules
    • 5.2.2 Soft Gelatin Capsules
  • 5.3 Non-gelatin Capsules

6 Global Empty Capsules Market, By Source

  • 6.1 Introduction
  • 6.2 Porcine
  • 6.3 Bovine
  • 6.4 Marine
  • 6.5 Natural

7 Global Empty Capsules Market, By Raw Material

  • 7.1 Introduction
  • 7.2 Hydroxy Propyl Methyl Cellulose (HPMC)
  • 7.3 Starch Materials
  • 7.4 Pullulan

8 Global Empty Capsules Market, By Functionality

  • 8.1 Introduction
  • 8.2 Immediate Release
  • 8.3 Sustained Release
  • 8.4 Delayed Release

9 Global Empty Capsules Market, By Application

  • 9.1 Introduction
  • 9.2 Antacid & Antiflatulent Preparations
  • 9.3 Dietary Supplements
  • 9.4 Cardiovascular Therapy Drugs
  • 9.5 Anti-inflammatory Drugs
  • 9.6 Antibiotic & Antibacterial Drugs
  • 9.7 Cough & Cold Drugs
  • 9.8 Antianemic Preparations
  • 9.9 Other Applications

10 Global Empty Capsules Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical & Biopharmaceutical Companies
  • 10.3 Nutraceutical Companies
  • 10.4 Other End Users

11 Global Empty Capsules Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 ACG Worldwide
  • 13.2 Bright Pharma Caps Inc
  • 13.3 CapsCanada Corporation
  • 13.4 Healthcaps India Ltd
  • 13.5 Lonza Group
  • 13.6 Medi-Caps Ltd
  • 13.7 Nectar Lifesciences Ltd
  • 13.8 Qingdao Yiqing Medicinal Capsules Co. Ltd
  • 13.9 Qualicaps Inc
  • 13.10 Roxlor LLC
  • 13.11 Shanxi JC Biological Technology Co. Ltd
  • 13.12 Snail Pharma Industry Co. Ltd
  • 13.13 Suheung Capsule Co. Ltd
  • 13.14 Sunil Healthcare Ltd

List of Tables

  • Table 1 Global Empty Capsules Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Empty Capsules Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Empty Capsules Market Outlook, By Gelatin Capsules (2021-2030) ($MN)
  • Table 4 Global Empty Capsules Market Outlook, By Hard Gelatin Capsules (2021-2030) ($MN)
  • Table 5 Global Empty Capsules Market Outlook, By Soft Gelatin Capsules (2021-2030) ($MN)
  • Table 6 Global Empty Capsules Market Outlook, By Non-gelatin Capsules (2021-2030) ($MN)
  • Table 7 Global Empty Capsules Market Outlook, By Source (2021-2030) ($MN)
  • Table 8 Global Empty Capsules Market Outlook, By Porcine (2021-2030) ($MN)
  • Table 9 Global Empty Capsules Market Outlook, By Bovine (2021-2030) ($MN)
  • Table 10 Global Empty Capsules Market Outlook, By Marine (2021-2030) ($MN)
  • Table 11 Global Empty Capsules Market Outlook, By Natural (2021-2030) ($MN)
  • Table 12 Global Empty Capsules Market Outlook, By Raw Material (2021-2030) ($MN)
  • Table 13 Global Empty Capsules Market Outlook, By Hydroxy Propyl Methyl Cellulose (HPMC) (2021-2030) ($MN)
  • Table 14 Global Empty Capsules Market Outlook, By Starch Materials (2021-2030) ($MN)
  • Table 15 Global Empty Capsules Market Outlook, By Pullulan (2021-2030) ($MN)
  • Table 16 Global Empty Capsules Market Outlook, By Functionality (2021-2030) ($MN)
  • Table 17 Global Empty Capsules Market Outlook, By Immediate Release (2021-2030) ($MN)
  • Table 18 Global Empty Capsules Market Outlook, By Sustained Release (2021-2030) ($MN)
  • Table 19 Global Empty Capsules Market Outlook, By Delayed Release (2021-2030) ($MN)
  • Table 20 Global Empty Capsules Market Outlook, By Application (2021-2030) ($MN)
  • Table 21 Global Empty Capsules Market Outlook, By Antacid & Antiflatulent Preparations (2021-2030) ($MN)
  • Table 22 Global Empty Capsules Market Outlook, By Dietary Supplements (2021-2030) ($MN)
  • Table 23 Global Empty Capsules Market Outlook, By Cardiovascular Therapy Drugs (2021-2030) ($MN)
  • Table 24 Global Empty Capsules Market Outlook, By Anti-inflammatory Drugs (2021-2030) ($MN)
  • Table 25 Global Empty Capsules Market Outlook, By Antibiotic & Antibacterial Drugs (2021-2030) ($MN)
  • Table 26 Global Empty Capsules Market Outlook, By Cough & Cold Drugs (2021-2030) ($MN)
  • Table 27 Global Empty Capsules Market Outlook, By Antianemic Preparations (2021-2030) ($MN)
  • Table 28 Global Empty Capsules Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Global Empty Capsules Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Empty Capsules Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 31 Global Empty Capsules Market Outlook, By Nutraceutical Companies (2021-2030) ($MN)
  • Table 32 Global Empty Capsules Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.